Published in Gene Therapy Weekly, December 12th, 2002
Scientists in Italy at the University of Padova reported the new finding in the of Journal of Clinical Endocrinology and Metabolism.
"A transcriptionally targeted retroviral vector for gene therapy of thyroid carcinomas was generated replacing the viral enhancer with the enhancer sequence of the human thyroglobulin (TG) gene, yielding a chimeric long-terminal repeat," described Luisa Barzon and colleagues.
Researchers compared its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.